Healthcare Press Releases
— To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology',
- Details
- Written by: DISC Surgery Center
- Category: Press Releases
DISC Surgery Center at Newport Beach ("DISC") has deepened its partnership with Blue Shield of California ("Blue Shield") to both advance and increase access to leading-edge spine care in the outpatient setting.Announcement is the result of a thoughtful and swift negotiation. DISC, through parent company TriasMD, was one of the first surgery centers in California to work directly with Blue Shield in 2023 to establish a new and expansive contract.
- Company Name: DISC Surgery Center
- Company/Org Logo:
- About Company: DISC Surgery Center at Newport Beach is a purpose-built outpatient facility focused on pioneering minimally invasive spine surgery, interventional pain management and orthopedic surgery. DISC is a subsidiary of TriasMD, a Chicago Pacific Founders portfolio company, and also an official partner of Red Bull Athlete Performance Center.
- Person of Contact: Kristien Brada-Thompson
- Designation: Manager
- Details
- Written by: PENTAX Medical
- Category: Press Releases
PENTAX Medical Americas, a division of HOYA Group, is excited to announce that it has obtained CE marks, clearing it for commercialization in the European Union for two of its latest innovations: the PENTAX Medical INSPIRA™ premium video processor and the i20c video endoscope series.
- Company Name: PENTAX Medical
- Company/Org Logo:
- About Company: PENTAX Medical is a division of HOYA Group. The company's mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. PENTAX Medical strives to align with the healthcare community's Triple Aim goals through transparent partnerships with its customers and by providing the highest quality solutions to help them reach their goals, including enabling customers to improve patient outcomes by offering evidence-based solutions across the continuum of care; ensuring value by supporting the customers to improve their efficiency and minimise their healthcare costs; and enriching patient and provider's experience by empowering every member of the care team to achieve optimal outcomes through products, education, and support. Focused on the outcome instead of technological features.
- Details
- Written by: Children's Minnesota
- Category: Press Releases
Children's Minnesota is thrilled to announce it is the first health system in North America to open a pediatric hybrid intraoperative magnetic resonance imaging (iMRI) suite equipped with both moving-scanner and moving-patient MRI technology in the same surgical space.
- Company Name: Children's Minnesota
- Company/Org Logo:
- About Company: Children's Minnesota is one of the largest pediatric health systems in the United States and the only health system in Minnesota to provide care exclusively to children, from before birth through young adulthood. An independent and not-for-profit system since 1924, Children's Minnesota is one system serving kids throughout the Upper Midwest at two free-standing hospitals, nine primary care clinics, multiple specialty clinics and seven rehabilitation sites. As The Kids ExpertsTM in our region, Children's Minnesota is regularly ranked by U.S. News & World Report as a top children's hospital.
- Details
- Written by: Co-Diagnostics
- Category: Press Releases
Co-Diagnostics, Inc.a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it has commenced clinical evaluations for its at-home and point-of-care Co-Dx PCR
- Company Name: Co-Diagnostics
- Company/Org Logo:
- About Company: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR Home™ platform and to locate genetic markers for use in applications other than infectious disease.
- Details
- Written by: Hologic Inc.
- Category: Press Releases
Hologic Inc. (Nasdaq: HOLX), a global leader in women's health, has announced approval of the NovaSure® V5 global endometrial ablation (GEA) device in Canada and Europe.
- Company Name: Hologic Inc.
- Company/Org Logo:
- About Company: Hologic Inc. is a global medical technology innovator primarily focused on improving women’s health and well-being through early detection and treatment. Its advancements include invention of the world’s first commercial 3D mammography system to find breast cancer; leadership in testing for cervical cancer, sexually transmitted infections, respiratory illnesses and the virus that causes COVID-19; and minimally invasive surgical technologies for uterine fibroids and abnormal uterine bleeding. The company also champions women through the Hologic Global Women’s Health Index, which provides a science-backed data roadmap for improving women’s well-being, and Project Health Equality, which elevates awareness, research insights and access to quality care for underserved women.
- Person of Contact: Jane Mazur
- Designation: Vice President, Communications
- Details
- Written by: Tasso, Inc.
- Category: Press Releases
Tasso, Inc., the leading provider of patient-centric, clinical-grade blood collection solutions, announced that the TassoOne™ Plus, a new high-volume liquid blood collection device, has received CE Mark certification and successfully fulfilled all of the performance,safety, and relevant product requirements.
- Company Name: Tasso, Inc.
- Company/Org Logo:
- About Company: Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders.
- Person of Contact: RJ Asplund
- Details
- Written by: Cardiawave SA
- Category: Press Releases
Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft®, an innovative non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults, announces the issuance of 3 new patents in the United States.
- Company Name: Cardiawave SA
- Company/Org Logo:
- About Company: Cardiawave has developed a non-invasive ultrasound therapy medical device for the treatment of valvular heart diseases, and in particular, Aortic Stenosis, the most prevalent heart valve disease in adults and one of the most common causes of cardiovascular mortality worldwide. Based near Paris, Cardiawave is a member of the national research consortium RHU Stop-AS, and has EN ISO 13485:2016 certification since 2019. Cardiawave employs 30 people and has secured over €22M in funding since its creation in 2014.
- Person of Contact: Benjamin Bertrand
- Designation: CEO
- Details
- Written by: LivaNova PLC
- Category: Press Releases
LivaNova announces limited commercial release of Essenz Perfusion System for cardiopulmonary bypass procedures in select European centers. The system includes a next-gen heart-lung machine and a patient monitor that provides data-driven decisions during life-saving CPB procedures.
- Company Name: LivaNova PLC
- Company/Org Logo:
- About Company: LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 3,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide.
- Person of Contact: Briana Gotlin
- Designation: Director
- Details
- Written by: BD
- Category: Press Releases
BD,a leading global medical technology company, had announced that it has received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV) to help combat illness in the current and future respiratory virus seasons.
- Company Name: BD
- Company/Org Logo:
- About Company: BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers,
- Details
- Written by: Preeclampsia Foundation
- Category: Press Releases
Preeclampsia Foundation Canada opens applications for 2023 Vision Grant program, announced at SMFM's.
- Company Name: Preeclampsia Foundation
- Company/Org Logo:
- About Company: Preeclampsia Foundation Canada was incorporated under the Canada Not-for-profit Corporations Act in May 2015. As an affiliate of the U.S. based Preeclampsia Foundation, its mission is to raise awareness and advance education and research of hypertensive disorders of pregnancy.
- Person of Contact: Laney Poye
- Designation: Director of Communications & Engagement
- BD introduces a high-throughput single-cell multiomics platform for expanded scientific discovery
- Aspivix's Carevix™, a novel cervical stabilizer, has received U.S. FDA 510(k) clearance
- Vizient Contract for Smoke Evacuation Portfolio Awarded to Olympus
- Mikart invests in new liquids and suspensions suite to enhance liquid oral drug
- Medline and Integrated UVC partner to offer cost-efficient surface and air UV disinfection device